Bolt Biotherapeutics, Inc. Profile Avatar - Palmy Investing

Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor recep…

Biotechnology
US, Redwood City [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
Worldwide · Subsidiaries Table
Subsidiary Private? Country City
- - - -
End of BOLT's Analysis
CIK: 1641281 CUSIP: 097702104 ISIN: US0977021049 LEI: - UEI: -
Secondary Listings
BOLT has no secondary listings inside our databases.